Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients.
Fiche publication
Date publication
janvier 2013
Journal
BMC infectious diseases
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DUVILLARD Laurence, Pr ORNETTI Paul
Tous les auteurs :
Ansemant T, Mahy S, Piroth C, Ornetti P, Ewing S, Guilland JC, Croisier D, Duvillard L, Chavanet P, Maillefert JF, Piroth L
Lien Pubmed
Résumé
Even though it has been suggested that antiretroviral therapy has an impact on severe hypovitaminosis D (SHD) in HIV infected patients, it could be speculated that the different levels of residual inflammation on HAART (Highly Active Anti Retroviral Therapy) could contribute to SHD and aggravate bone catabolism in these patients.
Mots clés
Adult, Aged, Antiretroviral Therapy, Highly Active, Biomarkers, metabolism, Bone and Bones, metabolism, Female, HIV Infections, complications, Humans, Inflammation Mediators, metabolism, Male, Middle Aged, Risk Factors, Vitamin D Deficiency, etiology, Young Adult
Référence
BMC Infect. Dis.. 2013 Jan;13:7